Skip to main content
. 2019 Mar 17;2019:7168949. doi: 10.1155/2019/7168949

Table 1.

Findings of the 15 patients living in the Puglia region of Italy whose swab, sputum, or BAL samples were positive for M. pneumoniae in January 2013 to April 2015.

Patient no. Age, years (sex) Sample type Hospitalized Susceptibility to macrolides (SNP) MLVA type MLVA profile P1 gene type
1 65 (F) BALa yes wt - - 1
2 80 (M) sputum no wt - - 2
3 87 (F) sputum no wt - - -
4 44 (M) BALa yes wt J (3/4/5/7/2) 1
5 32 (M) NPSb no R (A2063G) NCc (3/0/6/6/2) 2
6 62 (M) NPS no wt NCc (0/0/5/6/2) 2
7 61 (F) NPS no wt A (1/4/5/7/2) 1
8 20 (M) sputum yes wt NCc (5/0/5/6/2) 2
9 49 (M) NPS no wt NCc (7/0/6/5/2) 2
10 37 (F) BALc yes R (A2063G) Z (7/4/5/7/2) 1
11 37 (F) NPS no wt - - 1
12 18 (M) NPS yes wt - - 1
13 52 (M) NPS no wt - - 2
14 23 (F) sputum no wt NCc (3/0/6/7/2) 1
15 31 (F) NPS no R (A2064G) - - 2

a Bronchoalveolar Lavage.

b Nasopharyngeal swab.

c Not classifiable using the scheme proposed by Degrangè et al. (2009).

MLVA: multiple-locus variable-number tandem repeat analysis; R: resistant; SNP: single nucleotide polymorphism; wt: wild type.